Quetiapine fumarate is not a controlled substance. It does not appear on any of the five schedules of the Controlled Substances Act, and the FDA’s own prescribing label for Seroquel (the brand name) states this explicitly. You do need a prescription to get it, but it faces none of the extra restrictions that apply to controlled drugs like benzodiazepines or opioids.
What This Means for Your Prescription
Because quetiapine is not scheduled, it is not subject to the federal refill limits that govern controlled substances. Schedule III and IV drugs, for example, can only be refilled five times within six months of the original prescription date before a doctor must write a new one. Quetiapine has no such cap. Your doctor can authorize refills beyond that window, and pharmacies can process them without the additional verification steps required for scheduled medications.
You still cannot buy quetiapine over the counter. It is a prescription-only medication classified as an atypical antipsychotic. But in practical terms, getting refills is simpler: no special triplicate forms, no mandatory ID checks at the pharmacy counter, and no state prescription monitoring databases tracking each fill the way they do for opioids or stimulants.
Why People Ask This Question
The question usually comes up because quetiapine has well-known sedating effects and a documented pattern of misuse, which can make it feel like the kind of drug that should be controlled. Between 2005 and 2011, emergency department visits related to quetiapine misuse, abuse, suicide attempts, or adverse reactions increased 90%. The leading reason for those visits was nonmedical use.
Quetiapine’s sedation comes from its ability to block histamine receptors in the brain, the same mechanism behind drowsy antihistamines like diphenhydramine, just much stronger. It also blocks certain adrenaline receptors, which produces an anti-anxiety effect. Together, these properties make people feel what users describe as “mellow.” In surveys, 66.7% of people who misused quetiapine said they took it to recover from other substances, 25% used it to enhance the effects of other drugs, and about 21% were experimenting.
The drug has picked up street names including “quell,” “Susie Q,” “baby heroin,” and “squirrel,” with tablets selling for $3 to $8 each. Some people crush and snort the tablets or combine them with cocaine in a mix called a “Q-ball.” Misuse is particularly common in correctional settings, where it is sometimes called “jailhouse heroin” and used to self-treat insomnia, anxiety, or withdrawal from other substances.
Despite all of this, the DEA has not moved quetiapine to a controlled schedule. The drug does not produce euphoria in the way opioids or benzodiazepines do, and its primary effects (sedation and calm) are considered lower-risk for the kind of compulsive, escalating use pattern that typically triggers scheduling.
Approved Uses
Quetiapine is FDA-approved for three conditions: schizophrenia, manic episodes in bipolar I disorder, and depressive episodes in bipolar disorder. It is also approved as a maintenance treatment for bipolar I disorder when used alongside a mood stabilizer. Its effectiveness in schizophrenia is thought to come from blocking both dopamine and serotonin receptors in the brain, which helps reduce hallucinations, disorganized thinking, and mood instability.
Off-Label Use for Sleep
One of the biggest drivers of quetiapine prescriptions has nothing to do with its approved uses. Doctors frequently prescribe it at low doses for insomnia, and this practice has grown noticeably over the past two decades. The logic is straightforward: the drug is powerfully sedating, it is not a controlled substance (so it is easier to prescribe than sleep medications like zolpidem), and many patients with insomnia also have anxiety or depression that quetiapine may help.
This off-label use is controversial. Quetiapine carries significant side effects, including metabolic changes like weight gain and blood sugar elevation, that most traditional sleep aids do not. Adverse events and treatment dropouts due to side effects are common in clinical trials of quetiapine for sleep. Long-term safety data in people without psychiatric conditions is limited, and some experts argue that the risks outweigh the benefits when the only goal is better sleep. If your doctor has prescribed quetiapine primarily for insomnia, it is worth discussing the tradeoffs.
Discontinuation Can Cause Withdrawal-Like Symptoms
Even though quetiapine is not classified as addictive in the way controlled substances are, stopping it abruptly can produce a recognizable set of withdrawal-like symptoms. Published case reports describe nausea, vomiting, dizziness, headache, anxiety, rapid heartbeat, and lightheadedness beginning within a day of the last dose. In one case, the symptoms were severe enough to prevent normal daily activities.
This does not mean quetiapine is physically addictive in the traditional sense. Many non-addictive medications, including certain antidepressants and blood pressure drugs, cause rebound symptoms when stopped suddenly. The takeaway is practical: if you are discontinuing quetiapine, tapering gradually under medical guidance reduces the chance of these uncomfortable effects.